Latest Innovation News

Vicinity Centres reports a robust third quarter for FY25, driven by strong retailer demand and shopper confidence, highlighted by the successful launch of The Market Pavilion at Chadstone.

Vicinity Centres reports a robust third quarter for FY25, buoyed by record visitation at Chadstone’s new Market Pavilion and strong retail sales growth. The company now expects full-year earnings at the top end of guidance, underpinned by resilient portfolio metrics and strategic asset management.

Foresta Group Holdings’ subsidiary partners with New Zealand’s EECA to explore geothermal steam for its flagship biomass facility, aiming to boost sustainability and efficiency.

Epsilon Healthcare reports ongoing operational challenges post-voluntary administration while unveiling a new pharmacy subsidiary aimed at diversifying revenue streams and rebuilding market confidence.

Bio-Gene Technology Limited is progressing its development of two novel insecticidal compounds, Qcide and Flavocide, targeting major global markets with strong commercial validation and significant US Department of Defense funding.

Synertec Corporation reports a 7.7% revenue increase in FY25 Q3, highlights robust Powerhouse technology performance during extreme weather, and secures a US patent for its LNG Custody Transfer System.

4DMedical has landed a significant commercial contract with Intermountain Health to deploy its FDA-cleared Pulmonary Hypertension Analysis (PHA™) product, marking a key milestone in its U.S. expansion through a strategic Microsoft-backed partnership.

Bio-Gene Technology Limited has raised $2.1 million through a placement and launched a Share Purchase Plan to fund critical safety studies for its flagship insecticide Flavocide®, alongside development of Qcide and strategic initiatives.

Global uranium enrichment leader Urenco has agreed to invest A$5 million in Australian technology developer Ubaryon, forming a strategic partnership that validates and accelerates a novel uranium enrichment process.

AdAlta Limited has announced a pro rata renounceable rights offer to raise approximately $1.29 million, aiming to fund its strategic pivot towards licensing CAR-T cell therapies through its subsidiary AdCella. The offer includes new shares and options, underpinned by key insiders and an underwriting agreement.

XPON Technologies Group has acquired Alpha Digital for $1.72 million upfront plus performance earn-ins, immediately adding $4 million in recurring revenue and fast-tracking its path to profitability.

Next Science Limited has successfully had a derivative complaint dismissed in Florida, while continuing legal action against former employees for breach of post-employment restraints.